Cannabis Ruderalis

4-Bromo-3,5-dimethoxyamphetamine
Names
Preferred IUPAC name
1-(4-Bromo-3,5-dimethoxyphenyl)propan-2-amine
Other names
4-Bromo-3,5-dimethoxyamphetamine
2-(4-Bromo-3,5-dimethoxy-phenyl)-1-methyl-ethylamine
2-(4-Bromo-3,5-dimethoxyphenyl)ethan-1-methyl-amine
Identifiers
3D model (JSmol)
ChEMBL
ChemSpider
UNII
  • InChI=1S/C11H16BrNO2/c1-7(13)4-8-5-9(14-2)11(12)10(6-8)15-3/h5-7H,4,13H2,1-3H3 checkY
    Key: FAVLJTSHWBEOMA-UHFFFAOYSA-N checkY
  • InChI=1/C11H16BrNO2/c1-7(13)4-8-5-9(14-2)11(12)10(6-8)15-3/h5-7H,4,13H2,1-3H3
    Key: FAVLJTSHWBEOMA-UHFFFAOYAG
  • C1=C(C(=C(C=C1CC(C)N)OC)Br)OC
  • Brc1c(OC)cc(cc1OC)CC(N)C
Properties
C11H17BrNO2
Molar mass 275.166 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
☒N verify (what is checkY☒N ?)

4-Bromo-3,5-dimethoxyamphetamine is a lesser-known psychedelic drug and a substituted amphetamine. It was first synthesized by Alexander Shulgin. In his book PiHKAL, the dosage range is listed as 4–10 mg and the duration is listed as 8–12 hours.[1] It produces analgesia, numbness, and reduction of physical feeling. Very little data exists about its pharmacological properties, metabolism, and toxicity.

See also[edit]

References[edit]

  1. ^ "4-Bromo-3,5-dimethoxyamphetamine Entry in PiHKAL". Archived from the original on 2007-06-06. Retrieved 2007-03-28.

Leave a Reply